pembrolizumab,atezolizumab,derazantinib,vibostolimab,favezelimab
roche,basilea pharmaceutica,merck
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'fides-02', 'key,note,57', 'thank you']
thank you to of , for highlighting key findings from cohort b of the phase 2 keynote-057 trial, and the phase 1b/2 fides-02 study. head over to for more content! #gu23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.